Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
The values given for copeptin levels in men in quartiles 1 and 2 (Table 1) were incorrect, and should have read.
Although control of chronic glycemia in the population with diabetes and end-stage renal disease (ESRD) has been extensively studied in recent years, the unique problems of short-term glycemic management in acutely ill patients undergoing dialysis have received little attention. Bally et al. evaluated the role of a “closed-loop” (glucose sensor/algorithm tablet device/insulin pump) system in a cohort of hospitalized patients with type 2 diabetes receiving hemodialysis. Compared with usual care, the intervention group had superior glycemic control without increased hypoglycemic events.
Authors: Carretero-Anibarro E, Hamud-Uedha M PMID: 31427152 [PubMed - as supplied by publisher]
CONCLUSIONS: Dapagliflozin, in subjects with DM2, produces a medium to long-term decrease in arterial stiffness. PMID: 31420083 [PubMed - as supplied by publisher]
Macrophage (M ϕ) plasticity allows transition of Mϕs from an inflammatory to a reparative phenotype and is critical for wound healing. In pathologic conditions, such as type 2 diabetes (T2D), wounds fail to heal because of impaired resolution of inflammation. Although the mechanisms responsible for persistent T 2D inflammation are unknown, growing evidence indicates that the Toll-like receptor (TLR) 4 and saturated fatty acids (SFAs) drive Mϕ-mediated inflammation. Given the excess SFAs in T2D, we hypothesized that SFAs induce epigenetic alterations in wound Mϕs and drive Mϕ inflammation that impairs di abetic wound healing.
ConclusionBeside the improvements in the laboratory variables, the individualized FATmax training can also benefit daily physical capacity of older people with type 2 diabetes.
Publication date: September 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 9Author(s): Emma Ahlqvist, Tiinamaija Tuomi, Leif Groop
Publication date: September 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 9Author(s): John M Dennis, Beverley M Shields, William E Henley, Angus G Jones, Andrew T Hattersley
ConclusionsNontraditional factors, such as cultural practices and emotional functioning, are also important predictors of diabetes risk and should be considered when culturally tailoring diabetes prevention programs.RésuméObjectifsLes immigrants sud-asiatiques sont généralement en bonne santé à leur arrivée, mais développent rapidement le diabète après leur immigration. On ignore si des facteurs culturels et psychosociaux contribuent au risque de diabète dans ce groupe ethnique minoritaire. Les modèles de prédiction actuels portent p...
Background: There are concerns that dipeptidyl deptidase-4 (DPP-4) inhibitors, second- to third-line antidiabetic drugs, may be linked to the development of bullous pemphigoid, a rare but potentially severe autoimmune blistering skin condition. To address these concerns, we conducted a population-based study to determine whether the use of DPP-4 inhibitors, when compared with the use of other second- to third-line antidiabetic drugs, is associated with an increased risk of bullous pemphigoid in patients with type 2 diabetes.
Psoriasis is associated with inflammatory, metabolic and cardiovascular comorbidity. Psoriasis patients show various signs of low-grade systemic inflammation, which may contribute to the development of peripheral insulin resistance, type 2 diabetes and atherosclerosis. High-sensitivity C-reactive protein (hs-CRP) is regarded as a marker that is able to detect low-grade inflammatory processes. In this context, the correlation of certain psoriatic comorbidities and metabolic parameters with hs-CRP at baseline was examined.